Human progenitor cell recruitment via SDF-1α coacervate-laden PGS vascular grafts

Biomaterials

Volumn 34, Issue 38, 2013, Pages 9877-9885

  Lee, Kee Won ^a   Johnson, Noah R ^a   Gao, Jin ^a   Wang, Yadong ^a,b,c  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Coacervate; Human progenitor cells; Poly(glycerol sebacate); Polycation; Stromal cell derived factor (SDF) 1 ; Tissue engineering

Indexed keywords

COACERVATE; DRUG DELIVERY SYSTEM; LOADING EFFICIENCY; MESENCHYMAL PROGENITOR CELLS; POLIES (GLYCEROLSEBACATE); POLY(GLYCEROL SEBACATE); POLYCATIONS; PROGENITOR CELL;

BLOOD VESSELS; CYTOLOGY; DRUG DELIVERY; ENDOTHELIAL CELLS; GLYCEROL; GRAFTS; TISSUE ENGINEERING;

SCAFFOLDS (BIOLOGY);

ELASTOMER; GLYCEROL; HEPARIN; POLY(GLYCEROL SEBACATE); POLYCATION; STROMAL CELL DERIVED FACTOR 1; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ARTICLE; COACERVATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; REGENERATION; STEM CELL;

COACERVATE; HUMAN PROGENITOR CELLS; POLY(GLYCEROL SEBACATE); POLYCATION; STROMAL CELL-DERIVED FACTOR (SDF)-1Α; TISSUE ENGINEERING;

CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; DECANOATES; GLYCEROL; HUMANS; MESENCHYMAL STROMAL CELLS; POLYMERS; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84885390040     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.08.082     Document Type: Article

References (49)

1. Weinberg C.B., Bell E. Ablood vessel model constructed from collagen and cultured vascular cells. Science 1986, 231:397-400.
2. Niklason L.E., Gao J., Abbott W.M., Hirschi K.K., Houser S., Marini R., et al. Functional arteries grown invitro. Science 1999, 284:489-493.
3. L'Heureux N., Paquet S., Labbe R., Germain L., Auger F.A. Acompletely biological tissue-engineered human blood vessel. Faseb J 1998, 12:47-56.
4. Dahl S.L., Kypson A.P., Lawson J.H., Blum J.L., Strader J.T., Li Y., et al. Readily available tissue-engineered vascular grafts. Sci Transl Med 2011, 3:68ra9.
5. Quint C., Kondo Y., Manson R.J., Lawson J.H., Dardik A., Niklason L.E. Decellularized tissue-engineered blood vessel as an arterial conduit. Proc Natl Acad Sci U S A 2011, 108:9214-9219.
6. Matsumura G., Hibino N., Ikada Y., Kurosawa H., Shin'oka T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 2003, 24:2303-2308.
7. Shin'oka T., Matsumura G., Hibino N., Naito Y., Watanabe M., Konuma T., et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. JThorac Cardiovasc Surg 2005, 129:1330-1338.
8. Hibino N., Villalona G., Pietris N., Duncan D.R., Schoffner A., Roh J.D., et al. Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. Faseb J 2011, 25:2731-2739.
9. Roh J.D., Sawh-Martinez R., Brennan M.P., Jay S.M., Devine L., Rao D.A., et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A 2010, 107:4669-4674.
10. Wu W., Allen R.A., Wang Y. Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery. Nat Med 2012, 18:1148-1153.
11. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
12. Kaushal S., Amiel G.E., Guleserian K.J., Shapira O.M., Perry T., Sutherland F.W., et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded exvivo. Nat Med 2001, 7:1035-1040.
13. Schmidt D., Breymann C., Weber A., Guenter C.I., Neuenschwander S., Zund G., et al. Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts. Ann Thorac Surg 2004, 78:2094-2098.
14. Melero-Martin J.M., Khan Z.A., Picard A., Wu X., Paruchuri S., Bischoff J. Invivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 2007, 109:4761-4768.
15. Melero-Martin J.M., De Obaldia M.E., Kang S.Y., Khan Z.A., Yuan L., Oettgen P., et al. Engineering robust and functional vascular networks invivo with human adult and cord blood-derived progenitor cells. Circ Res 2008, 103:194-202.
16. Allen P., Melero-Martin J., Bischoff J. Type I collagen, fibrin and PuraMatrix matrices provide permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networks. JTissue Eng Regen Med 2011, 5:e74-86.
17. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283:845-848.
18. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., et al. Stromal cell-derived factor-1 effects on exvivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
19. De Falco E., Porcelli D., Torella A.R., Straino S., Iachininoto M.G., Orlandi A., et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004, 104:3472-3482.
20. Misra P., Lebeche D., Ly H., Schwarzkopf M., Diaz G., Hajjar R.J., et al. Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha. JNucl Med 2008, 49:963-969.
21. McQuibban G.A., Butler G.S., Gong J.H., Bendall L., Power C., Clark-Lewis I., et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. JBiol Chem 2001, 276:43503-43508.
22. Schantz J.T., Chim H., Whiteman M. Cell guidance in tissue engineering: SDF-1 mediates site-directed homing of mesenchymal stem cells within three-dimensional polycaprolactone scaffolds. Tissue Eng 2007, 13:2615-2624.
23. Thevenot P.T., Nair A.M., Shen J., Lotfi P., Ko C.Y., Tang L. The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 2010, 31:3997-4008.
24. Ko I.K., Ju Y.M., Chen T., Atala A., Yoo J.J., Lee S.J. Combined systemic and local delivery of stem cell inducing/recruiting factors for in situ tissue regeneration. Faseb J 2012, 26:158-168.
25. Yu J., Wang A., Tang Z., Henry J., Li-Ping Lee B., Zhu Y., et al. The effect of stromal cell-derived factor-1alpha/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration. Biomaterials 2012, 33:8062-8074.
26. He X., Ma J., Jabbari E. Migration of marrow stromal cells in response to sustained release of stromal-derived factor-1alpha from poly(lactide ethylene oxide fumarate) hydrogels. Int J Pharm 2010, 390:107-116.
27. Kimura Y., Tabata Y. Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. JBiomater Sci Polym Ed 2010, 21:37-51.
28. Prokoph S., Chavakis E., Levental K.R., Zieris A., Freudenberg U., Dimmeler S., et al. Sustained delivery of SDF-1alpha from heparin-based hydrogels to attract circulating pro-angiogenic cells. Biomaterials 2012, 33:4792-4800.
29. Purcell B.P., Elser J.A., Mu A., Margulies K.B., Burdick J.A. Synergistic effects of SDF-1alpha chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium. Biomaterials 2012, 33:7849-7857.
30. Huang Y.C., Liu T.J. Mobilization of mesenchymal stem cells by stromal cell-derived factor-1 released from chitosan/tripolyphosphate/fucoidan nanoparticles. Acta Biomater 2012, 8:1048-1056.
31. Chu H., Johnson N.R., Mason N.S., Wang Y. A[polycation:heparin] complex releases growth factors with enhanced bioactivity. JControl Release 2011, 150:157-163.
32. Chu H., Gao J., Chen C.W., Huard J., Wang Y. Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis. Proc Natl Acad Sci U S A 2011, 108:13444-13449.
33. Chu H., Chen C.W., Huard J., Wang Y. The effect of a heparin-based coacervate of fibroblast growth factor-2 on scarring in the infarcted myocardium. Biomaterials 2013, 34:1747-1756.
34. Johnson N.R., Wang Y. Controlled delivery of heparin-binding EGF-like growth factor yields fast and comprehensive wound healing. JControl Release 2013, 166:124-129.
35. Wang Y., Ameer G.A., Sheppard B.J., Langer R. Atough biodegradable elastomer. Nat Biotechnol 2002, 20:602-606.
36. Gao J., Crapo P.M., Wang Y. Macroporous elastomeric scaffolds with extensive micropores for soft tissue engineering. Tissue Eng 2006, 12:917-925.
37. Lee K.W., Wang Y. Elastomeric PGS scaffolds in arterial tissue engineering. JVis Exp 2011, (50):e2691.
38. Amara A., Lorthioir O., Valenzuela A., Magerus A., Thelen M., Montes M., et al. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. JBiol Chem 1999, 274:23916-23925.
39. Murphy J.W., Cho Y., Sachpatzidis A., Fan C., Hodsdon M.E., Lolis E. Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin. JBiol Chem 2007, 282:10018-10027.
40. Cross D.P., Wang C. Stromal-derived factor-1 alpha-loaded PLGA microspheres for stem cell recruitment. Pharm Res 2011, 28:2477-2489.
41. Zern B.J., Chu H., Wang Y. Control growth factor release using a self-assembled [polycation:heparin] complex. PLoS One 2010, 5:e11017.
42. Ponte A.L., Marais E., Gallay N., Langonne A., Delorme B., Herault O., et al. The invitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25:1737-1745.
43. Wynn R.F., Hart C.A., Corradi-Perini C., O'Neill L., Evans C.A., Wraith J.E., et al. Asmall proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004, 104:2643-2645.
44. Noort W.A., Kruisselbrink A.B., in't Anker P.S., Kruger M., van Bezooijen R.L., de Paus R.A., et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002, 30:870-878.
45. De Visscher G., Mesure L., Meuris B., Ivanova A., Flameng W. Improved endothelialization and reduced thrombosis by coating a synthetic vascular graft with fibronectin and stem cell homing factor SDF-1alpha. Acta Biomater 2012, 8:1330-1338.
46. Lapidot T. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Ann N Y Acad Sci 2001, 938:83-95.
47. Nagasawa T., Tachibana K., Kishimoto T. Anovel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection. Semin Immunol 1998, 10:179-185.
48. Ori A., Wilkinson M.C., Fernig D.G. Asystems biology approach for the investigation of the heparin/heparan sulfate interactome. JBiol Chem 2011, 286:19892-19904.
49. Johnson N.R., Wang Y. Controlled delivery of sonic hedgehog morphogen and its potential for cardiac repair. PLoS One 2013, 8:e63075.